This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

11 Jul 2013

EMA approves Votrient following positive clinical trial results

The EMA has approved Votrient following the publication of positive clinical trial results.


The European Medicines Agency (EMA) has lifted the conditional status of and fully approved GlaxoSmithKline's (GSK's) anti-cancer drug Votrient (pazopanib).

Related News